Tisdag 29 April | 19:40:10 Europe / Stockholm

Kalender

Est. tid*
2026-10-23 07:00 Kvartalsrapport 2026-Q3
2026-07-24 07:00 Kvartalsrapport 2026-Q2
2026-04-27 07:00 Kvartalsrapport 2026-Q1
2026-02-02 N/A Bokslutskommuniké 2025
2025-11-04 07:00 Kvartalsrapport 2025-Q3
2025-07-29 07:00 Kvartalsrapport 2025-Q2
2025-05-12 N/A X-dag ordinarie utdelning PHIA 0.85 EUR
2025-05-08 N/A Årsstämma
2025-05-06 07:00 Kvartalsrapport 2025-Q1
2025-02-19 - Bokslutskommuniké 2024
2024-10-28 - Kvartalsrapport 2024-Q3
2024-07-29 - Kvartalsrapport 2024-Q2
2024-05-07 - Årsstämma
2024-04-29 - Kvartalsrapport 2024-Q1
2024-01-29 - Bokslutskommuniké 2023
2023-10-23 - Kvartalsrapport 2023-Q3
2023-07-24 - Kvartalsrapport 2023-Q2
2023-05-11 - X-dag ordinarie utdelning PHIA 0.85 EUR
2023-05-09 - Årsstämma
2023-04-24 - Kvartalsrapport 2023-Q1
2023-02-21 - Bokslutskommuniké 2022
2022-10-24 - Kvartalsrapport 2022-Q3
2022-09-30 - Extra Bolagsstämma
2022-07-25 - Kvartalsrapport 2022-Q2
2022-05-12 - X-dag ordinarie utdelning PHIA 0.85 EUR
2022-05-10 - Årsstämma
2022-04-25 - Kvartalsrapport 2022-Q1
2022-01-24 - Bokslutskommuniké 2021
2021-10-18 - Kvartalsrapport 2021-Q3
2021-07-26 - Kvartalsrapport 2021-Q2
2021-05-10 - X-dag ordinarie utdelning PHIA 0.85 EUR
2021-05-06 - Årsstämma
2021-04-26 - Kvartalsrapport 2021-Q1
2021-01-25 - Bokslutskommuniké 2020
2020-10-19 - Kvartalsrapport 2020-Q3
2020-07-20 - Kvartalsrapport 2020-Q2
2020-06-26 - Extra Bolagsstämma
2020-05-05 - X-dag ordinarie utdelning PHIA 0.85 EUR
2020-04-30 - Årsstämma
2020-04-20 - Kvartalsrapport 2020-Q1
2020-01-28 - Bokslutskommuniké 2019
2019-10-28 - Kvartalsrapport 2019-Q3
2019-07-22 - Kvartalsrapport 2019-Q2
2019-04-29 - Kvartalsrapport 2019-Q1
2024-05-15 11:00:00

May 15, 2024

Amsterdam, the Netherlands – Royal Philips (NYSE: PHG, AEX: PHIA), today announced that the exchange ratio for the dividend for the year 2023 is 1 new common share for every 29.2684 existing common shares. This ratio was based on the volume weighted average price on Euronext Amsterdam of May 9, 10 and 13, 2024, of EUR 24.8481 and was calculated in a manner that the gross dividend in shares will be approximately equal to EUR 0.85. As a result, Philips will issue a total number of 30,860,582 new common shares.

Distribution of the dividend with delivery of new common shares and settlement of any fractions in cash, will take place from May 16, 2024. Upon distribution, the total issued share capital will amount to EUR 188,875,310 representing 944,376,548 common shares.

In the second quarter, Philips intends to cancel 4,437,164 shares that were acquired under the now completed EUR 1.5 billion share repurchase program for capital reduction purposes, as announced on July 26, 2021. Post cancellation, the total number of issued shares will amount to 939,939,384 common shares. More information is available via this link.

For further information, please contact:

Ben Zwirs
Philips External Relations
Tel.: +31 6 1521 3446
E-mail: ben.zwirs@philips.com

Dorin Danu
Philips Investor Relations
Tel.: +31 20 59 77055
E-mail: dorin.danu@philips.com

About Royal Philips
Royal Philips (NYSE: PHG, AEX: PHIA) is a leading health technology company focused on improving people's health and well-being through meaningful innovation. Philips’ patient- and people-centric innovation leverages advanced technology and deep clinical and consumer insights to deliver personal health solutions for consumers and professional health solutions for healthcare providers and their patients in the hospital and the home. Headquartered in the Netherlands, the company is a leader in diagnostic imaging, ultrasound, image-guided therapy, monitoring, and enterprise informatics, as well as in personal health. Philips generated 2023 sales of EUR 18.2 billion and employs approximately 69,100 employees with sales and services in more than 100 countries. News about Philips can be found at www.philips.com/newscenter.

Forward-looking statements
This release contains certain forward-looking statements with respect to the financial condition, results of operations and business of Philips and certain of the plans and objectives of Philips with respect to these items. Examples of forward-looking statements include statements made about the strategy, estimates of sales growth, future EBITA, future developments in Philips’ organic business and the completion of acquisitions and divestments. By their nature, these statements involve risk and uncertainty because they relate to future events and circumstances and there are many factors that could cause actual results and developments to differ materially from those expressed or implied by these statements.